home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops  
 

Webinar On IQ, OQ, PQ in the Verification and Validation Process

 
  August 07, 2015  
     
 


Compliance Trainings, Online
2015-08-18


Description :

This webinar will discuss the Consideration of IQ, OQ, and PQ and their equivalents for processes, equipment (production and test), product, and CGMP e-records / e-signatures.

FDA Warning Letters and recent high-profile recalls indicate major cGMP deficiencies in big name device and pharma companies, many going back to insufficient, poor or non-existent product / equipment / process V&V requirements and execution. And now the FDA is taking an even tougher stance.

Why do companies need robust V&V?

What are the "must have" elements from  the CGMPs and best practices?

How do you define and use IQ, OQ, PQ, or their equivalents?

How do ISO 14971 and ICH Q9 for hazard analysis and product risk management factor in and assist to allocating limited company resources?

How can these be integrated into the company's quality management system?

While focused on CGMP compliance, it is suitable for ISO 13485 and ISO 9001 (international / global) compliance as well.

Areas Covered in the Session :

IQ, OQ, and PQ, major components of robust Verification and Validation V&V programs - Regulatory requirements

The Master Validation Plan(s)

Individual V&V Plans and their execution

Product Verification and Validation

Process and Equipment V&V; including software

QMS V&V and 21 CFR Part 11

When / How to Use DQ, IQ, OQ, PQ, or ASTM E2500 Equivalents

The 11 Elements of the FDA's Software VT&V "Model"

Incorporating the Hazard Analysis / Risk Management tools of ISO 14971 or ICH Q9

How to Avoid recent compliance problems

Who Will Benefit:

This webinar will provide valuable assistance to all regulated companies that need to review and modify their company's planning and execution of verification and validation, based on a proper understanding of the roles of IQ, OQ, and PQ, or equivalent terminology. Its principles apply to personnel / companies in the Medical Devices, Pharmaceutical, Diagnostic, and Biologics fields. The employees who will benefit include:

Senior management

Middle management

Research & Development

Engineering

Software

QA / RA

Manufacturing

Operators

Consultants

cGMP instructors

 

All personnel involved in verification and/or validation planning, execution and documentation.

 
 
Organized by: Compliance Trainings
Invited Speakers: John E. Lincoln, is Principal of J. E. Lincoln and Associates LLC, a consulting company with over 33 years experience in U.S. FDA-regulated industries, 19 years as a full-time consultant. John has worked with companies from start-up to Fortune 100, in the U.S., Mexico, Canada, France, Germany, Sweden, China and Taiwan. He specializes in quality assurance, regulatory affairs, QMS problem remediation and FDA responses, new / changed product 510(k)s, process / product / equipment including QMS and software validations, ISO 14971 product risk management files / reports, Design Control / Design History Files, Technical Files.

 
Deadline for Abstracts: 2015-08-17
 
Registration:

For more information about this event please visit

 

https://compliancetrainings.com/SiteEngine/ProductDetailView.aspx?id=MD1544

E-mail: suzzane.d@compliancetrainings.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.